Product Information

ABIRATERONE ACETATE 250 MG TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.7746 per EA under NDC 68462013508. Its NADAC has been published 227 times since Apr 20, 2022.

FDA first approved this application on Oct 16, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ABIRATERONE ACETATE 250 MG TAB

abiraterone acetate
$0.7746per EA

Strength

250 mg/1

NDC

68462013508

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ABIRATERONE ACETATE

Approval Type

Generic (ANDA)

FDA Application

ANDA209227

FDA Approved

10/16/2019

TE Code

AB

On Market Since

10/16/2019

Pharmacological Classes

Cytochrome P450 17A1 Inhibitor
Cytochrome P450 17A1 Inhibitors
Cytochrome P450 2C8 Inhibitors
Cytochrome P450 2D6 Inhibitors

Price Statistics

The NADAC for ABIRATERONE ACETATE 250 MG TAB has been published 227 times since Apr 20, 2022, and over the history we have for it it has declined 59.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7746 per EA
All-time high$1.9092 (Aug 10, 2022)
All-time low$0.6920 (Jul 17, 2024)
52-week high$1.0638
52-week low$0.7746
Median price$1.0192
Average price$1.1899
Largest weekly change-43.0% (Sep 20, 2023)
Weeks tracked227
Tracking sinceApr 20, 2022

Price History

1W

-3.6%

1M

-3.6%

3M

-8.9%

6M

-6.9%

1Y

-24.0%

3Y

-52.0%

5Y

N/A

All

-59.4%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ABIRATERONE ACETATE 250 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for ABIRATERONE ACETATE 250 MG TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.7746 per EA (NDC 68462013508), effective Aug 19, 2026.

How has the price of ABIRATERONE ACETATE 250 MG TAB changed over time?

Over the history we have for it, the NADAC for ABIRATERONE ACETATE 250 MG TAB has declined 59.4%. It has been tracked across 227 weekly CMS publications since Apr 20, 2022.

What are the highest and lowest recorded NADAC prices for ABIRATERONE ACETATE 250 MG TAB?

Since Apr 20, 2022, the NADAC for ABIRATERONE ACETATE 250 MG TAB has ranged from a low of $0.6920 (Jul 17, 2024) to a high of $1.9092 (Aug 10, 2022), with a median of $1.0192 per EA.

Are there cheaper alternatives to ABIRATERONE ACETATE 250 MG TAB?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ABIRATERONE ACETATE 250 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures ABIRATERONE ACETATE 250 MG TAB?

ABIRATERONE ACETATE 250 MG TAB (NDC 68462013508) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.